Skip to the main content.

Outcome-Driven Solutions for Medtech Challenges

Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.

Purpose-built solutions. Proven results. User & Patient-centered innovation.

 

Purpose-Built for Breakthroughs

Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity.  Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.  

We are the Innovation CRO.

Legacy of excellence. Proven execution. Patient impact accelerated.

 

Veranex Blog

9 min read

Addressing Inequity in Healthcare – A Case Study of Tackling Liver Cancer in New Zealand

The following article illustrates how inequities arise in healthcare, one disease at a time. It highlights insights from a program we are currently working on with Roche that aims to reduce healthcare inequities in New Zealand particularly...

Read More

2 min read

The New Normal for Market Access in China: Volume Based Procurement

Our previous update1, Analysis of China’s First National Tender on Coronary Stents, discussed the first national-level centralized tender for a...

Read More

2 min read

Meet the Team: Meghana Kapoor, Manager, Clinical Data Management

In this installment of our “Meet the Team” blog series, we talk to Meghana Kapoor, Manager, Clinical Data Management, about her background, her...

Read More

2 min read

Meet the Team: Soma Sekhar Koramatla, Associate Manager, Statistical Programming, Biometrics

In this installment of our “Meet the Team” blog series, we talk to Soma Sekhar Koramatla, Associate Manager, Statistical Programming, Biometrics...

Read More

3 min read

5 Compelling Reasons to Go Functional Service Provider (FSP)

Given the shifts that Contract Research Organizations (CROs) and the pharma industry have gone through with the COVID-19 pandemic and subsequent...

Read More

2 min read

The Regulatory Constraints in Making Your LDT/CDx Partnership Choices in China

Our previous blog discussed the emerging trends for the companion diagnostics (CDx) regulations in China. There have been several developments since...

Read More

2 min read

A Data Management Perspective: How Are Device Trials Different from Drug Trials?

Many articles discussing the difference between drug and device trials come from a regulatory perspective on how clinical trials are designed and...

Read More

2 min read

Meeting Early Phase Study Challenges – a Data Management Perspective

First-in-Human studies are a discovery point, which can decide the fate of a compound as well as lay the groundwork for subsequent phases of a...

Read More

2 min read

How COVID Changed the Diagnostic Industry – for Better

It goes without saying that the pandemic has disrupted all aspects of our lives especially the healthcare system, including the diagnostic industry....

Read More